NSUN2-mediated m 5 C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2/SRSF6/UAP1 signaling axis
Theranostics · 27.01.2025 · 15 (7) · 2757-2777
DOI: 10.7150/thno.104713 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, erschienen am 27.01.2025. Verfasst von Xiukun Hou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thyroid and Neck Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key La…. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Alternative Splicing, Drug Resistance, Neoplasm, Thyroid Neoplasms. Die Arbeit wurde bisher 46-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Thyroid and Neck Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research…
- Department of Thyroid and Breast Surgery, Tianjin Union Medical Center, Tianjin 300121, China.
- Tianjin Key Laboratory of General Surgery in Construction, Tianjin Union Medical Center, Tianjin 300121, China.
- School of Medicine, Nankai University, Tianjin 300071, China.
Zitieren
APA
Hou, X., Dong, Q., Hao, J., Liu, M., Ning, J., Tao, M., Wang, Z., Guo, F., Huang, D., Shi, X., Gao, M., Li, D., & Zheng, X. (2025). NSUN2-mediated m 5 C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2/SRSF6/UAP1 signaling axis. Theranostics, 15(7), 2757-2777. https://doi.org/10.7150/thno.104713
Vancouver
Hou X, Dong Q, Hao J, Liu M, Ning J, Tao M, et al. NSUN2-mediated m 5 C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2/SRSF6/UAP1 signaling axis. Theranostics. 2025;15(7):2757-2777. doi:10.7150/thno.104713
BibTeX
@article{Hou2025,
author = {Hou, Xiukun and Dong, Qiman and Hao, Jie and Liu, Min and Ning, Junya and Tao, Mei and Wang, Zhongyu and Guo, Fengli and Huang, Dongmei and Shi, Xianle and Gao, Ming and Li, Dapeng and Zheng, Xiangqian},
title = {NSUN2-mediated m 5 C modification drives alternative splicing reprogramming and promotes multidrug resistance in anaplastic thyroid cancer through the NSUN2/SRSF6/UAP1 signaling axis},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {7},
pages = {2757--2777},
doi = {10.7150/thno.104713}
}
EUVIMED